A randomised controlled trial of oral prednisolone for viral-wheeze in pre-school children with stratification for serum level of Eosinophil Protein X (EPX)

ISRCTN ISRCTN78625210
DOI https://doi.org/10.1186/ISRCTN78625210
Secondary identifying numbers AM2/01/008
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
13/03/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Jonathan Grigg
Scientific

University of Leicester
Leicester Royal Infirmary
P.O. Box 65
Leicester
LE2 7LX
United Kingdom

Phone +44 (0)116 252 5840
Email jg33@leicester.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study objectivesThis study will test the hypothesis that in preschool children with viral-wheeze, those with atopic pulmonary inflammation will respond to a short course of oral corticosteroids, whereas those with a structurally based vulnerability to wheeze will not.
Ethics approval(s)Not provided at time of registration.
Health condition(s) or problem(s) studiedRespiratory tract diseases: Asthma
InterventionChildren passing the inclusion criteria will be divided into two groups
a. Those with presenting serum EPX levels of greater than or equal to 25 ug/l
b. Those with EPX levels <25 ug/l.
At the next episode of viral wheeze children in both groups will receive either placebo or a short course of oral prednisolone.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Prednisolone
Primary outcome measureOutcome will be assessed by parental scoring of respiratory symptoms using a diary card.
Secondary outcome measuresNo secondary outcome measures
Overall study start date01/03/1999
Completion date28/02/2002

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit18 Months
Upper age limit48 Months
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteriaChildren aged between 18 and 48 months of age presenting with viral-wheeze.
Key exclusion criteriaNo exclusion criteria
Date of first enrolment01/03/1999
Date of final enrolment28/02/2002

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

University of Leicester
Leicester
LE2 7LX
United Kingdom

Sponsor information

Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Government

NHS Asthma National Research and Development Programme (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Abstract results 01/11/2003 No No